Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function

Joseph A Hill, Beverly A Rothermel, Ki Dong Yoo, Barry Cabuay, Elaine Demetroulis, Robert M. Weiss, William Kutschke, Rhonda S Bassel-Duby, R. Sanders Williams

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Calcineurin is a Ca2+/calmodulin-activated protein phosphatase that transduces hypertrophic stimuli to regulate transcriptional control of myocyte transformation. It is not known whether overexpression of MCIP1, a recently described endogenous inhibitor of calcineurin, impacts the hypertrophic response to pathophysiologically relevant pressure overload. Further, the functional consequences of calcineurin inhibition by MCIP1 under conditions of hemodynamic stress are unknown. Transgenic mice expressing a human cDNA encoding hMCIP1 in the myocardium were subjected to thoracic aortic banding. Transgenic mice and wild type littermates tolerated pressure overload equally well. Wild type mice developed left ventricular hypertrophy, but the hypertrophic response in transgenics was significantly blunted. An isoform of MCIP1 transcript was up-regulated by pressure stress, whereas MCIP2 transcript was not. Expression patterns of fetal genes were differentially regulated in banded MCIP1 hearts compared with wild type. Echocardiography performed at 3 weeks and 3 months revealed preservation of both left ventricular size and systolic function in banded MCIP1 mice despite the attenuated hypertrophic response. These data demonstrate attenuation of hypertrophic transformation when calcineurin is inhibited by MCIP1. Further, these data suggest that activation of hypertrophic marker genes may not be directly dependent on calcineurin activity. Finally, they demonstrate that ventricular performance is preserved despite attenuation of compensatory hypertrophy.

Original languageEnglish (US)
Pages (from-to)10251-10255
Number of pages5
JournalJournal of Biological Chemistry
Volume277
Issue number12
DOIs
StatePublished - Mar 22 2002

Fingerprint

Calcineurin
Cardiomegaly
Pressure
Transgenic Mice
Genes
Echocardiography
Phosphoprotein Phosphatases
Hemodynamics
Left Ventricular Hypertrophy
Calmodulin
Muscle Cells
Hypertrophy
Myocardium
Protein Isoforms
Thorax
Complementary DNA
Chemical activation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. / Hill, Joseph A; Rothermel, Beverly A; Yoo, Ki Dong; Cabuay, Barry; Demetroulis, Elaine; Weiss, Robert M.; Kutschke, William; Bassel-Duby, Rhonda S; Sanders Williams, R.

In: Journal of Biological Chemistry, Vol. 277, No. 12, 22.03.2002, p. 10251-10255.

Research output: Contribution to journalArticle

Hill, Joseph A ; Rothermel, Beverly A ; Yoo, Ki Dong ; Cabuay, Barry ; Demetroulis, Elaine ; Weiss, Robert M. ; Kutschke, William ; Bassel-Duby, Rhonda S ; Sanders Williams, R. / Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 12. pp. 10251-10255.
@article{7b2e9a0528394aa1a1e5826a290d071c,
title = "Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function",
abstract = "Calcineurin is a Ca2+/calmodulin-activated protein phosphatase that transduces hypertrophic stimuli to regulate transcriptional control of myocyte transformation. It is not known whether overexpression of MCIP1, a recently described endogenous inhibitor of calcineurin, impacts the hypertrophic response to pathophysiologically relevant pressure overload. Further, the functional consequences of calcineurin inhibition by MCIP1 under conditions of hemodynamic stress are unknown. Transgenic mice expressing a human cDNA encoding hMCIP1 in the myocardium were subjected to thoracic aortic banding. Transgenic mice and wild type littermates tolerated pressure overload equally well. Wild type mice developed left ventricular hypertrophy, but the hypertrophic response in transgenics was significantly blunted. An isoform of MCIP1 transcript was up-regulated by pressure stress, whereas MCIP2 transcript was not. Expression patterns of fetal genes were differentially regulated in banded MCIP1 hearts compared with wild type. Echocardiography performed at 3 weeks and 3 months revealed preservation of both left ventricular size and systolic function in banded MCIP1 mice despite the attenuated hypertrophic response. These data demonstrate attenuation of hypertrophic transformation when calcineurin is inhibited by MCIP1. Further, these data suggest that activation of hypertrophic marker genes may not be directly dependent on calcineurin activity. Finally, they demonstrate that ventricular performance is preserved despite attenuation of compensatory hypertrophy.",
author = "Hill, {Joseph A} and Rothermel, {Beverly A} and Yoo, {Ki Dong} and Barry Cabuay and Elaine Demetroulis and Weiss, {Robert M.} and William Kutschke and Bassel-Duby, {Rhonda S} and {Sanders Williams}, R.",
year = "2002",
month = "3",
day = "22",
doi = "10.1074/jbc.M110722200",
language = "English (US)",
volume = "277",
pages = "10251--10255",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function

AU - Hill, Joseph A

AU - Rothermel, Beverly A

AU - Yoo, Ki Dong

AU - Cabuay, Barry

AU - Demetroulis, Elaine

AU - Weiss, Robert M.

AU - Kutschke, William

AU - Bassel-Duby, Rhonda S

AU - Sanders Williams, R.

PY - 2002/3/22

Y1 - 2002/3/22

N2 - Calcineurin is a Ca2+/calmodulin-activated protein phosphatase that transduces hypertrophic stimuli to regulate transcriptional control of myocyte transformation. It is not known whether overexpression of MCIP1, a recently described endogenous inhibitor of calcineurin, impacts the hypertrophic response to pathophysiologically relevant pressure overload. Further, the functional consequences of calcineurin inhibition by MCIP1 under conditions of hemodynamic stress are unknown. Transgenic mice expressing a human cDNA encoding hMCIP1 in the myocardium were subjected to thoracic aortic banding. Transgenic mice and wild type littermates tolerated pressure overload equally well. Wild type mice developed left ventricular hypertrophy, but the hypertrophic response in transgenics was significantly blunted. An isoform of MCIP1 transcript was up-regulated by pressure stress, whereas MCIP2 transcript was not. Expression patterns of fetal genes were differentially regulated in banded MCIP1 hearts compared with wild type. Echocardiography performed at 3 weeks and 3 months revealed preservation of both left ventricular size and systolic function in banded MCIP1 mice despite the attenuated hypertrophic response. These data demonstrate attenuation of hypertrophic transformation when calcineurin is inhibited by MCIP1. Further, these data suggest that activation of hypertrophic marker genes may not be directly dependent on calcineurin activity. Finally, they demonstrate that ventricular performance is preserved despite attenuation of compensatory hypertrophy.

AB - Calcineurin is a Ca2+/calmodulin-activated protein phosphatase that transduces hypertrophic stimuli to regulate transcriptional control of myocyte transformation. It is not known whether overexpression of MCIP1, a recently described endogenous inhibitor of calcineurin, impacts the hypertrophic response to pathophysiologically relevant pressure overload. Further, the functional consequences of calcineurin inhibition by MCIP1 under conditions of hemodynamic stress are unknown. Transgenic mice expressing a human cDNA encoding hMCIP1 in the myocardium were subjected to thoracic aortic banding. Transgenic mice and wild type littermates tolerated pressure overload equally well. Wild type mice developed left ventricular hypertrophy, but the hypertrophic response in transgenics was significantly blunted. An isoform of MCIP1 transcript was up-regulated by pressure stress, whereas MCIP2 transcript was not. Expression patterns of fetal genes were differentially regulated in banded MCIP1 hearts compared with wild type. Echocardiography performed at 3 weeks and 3 months revealed preservation of both left ventricular size and systolic function in banded MCIP1 mice despite the attenuated hypertrophic response. These data demonstrate attenuation of hypertrophic transformation when calcineurin is inhibited by MCIP1. Further, these data suggest that activation of hypertrophic marker genes may not be directly dependent on calcineurin activity. Finally, they demonstrate that ventricular performance is preserved despite attenuation of compensatory hypertrophy.

UR - http://www.scopus.com/inward/record.url?scp=0037155929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037155929&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110722200

DO - 10.1074/jbc.M110722200

M3 - Article

C2 - 11786544

AN - SCOPUS:0037155929

VL - 277

SP - 10251

EP - 10255

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 12

ER -